Replies to post #235906 on Biotech Values

[dewophile]

Yes ASMB data questioning ability of DAAs to achieve a functional cure
PS for those not following ENTA closely they are working on a novel MOA in HBV w the goal of a 3 drug oral cocktail. It’s a long shot but if it works the opportunity is larger than HCV. It’s the kind of opportunity I think a large pharma would take a flier on before final results are in